Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.

Porwit A, Béné MC.

Cytometry B Clin Cytom. 2019 May;96(3):183-194. doi: 10.1002/cyto.b.21783. Epub 2019 Apr 29. Review. Erratum in: Cytometry B Clin Cytom. 2019 Jul;96(4):323.

PMID:
31033213
2.

In memoriam: Professor Olga Mioduszewska.

Porwit A, Ziarkiewicz-Wróblewska B, Walewski J.

Pol J Pathol. 2018;69(3):207-208. doi: 10.5114/pjp.2018.79539. No abstract available.

3.

Advances in Bone Marrow Diagnostics of Patients with Cytopenia.

Porwit A, Ziarkiewicz-Wroblewska B.

Pathobiology. 2019;86(1):5-6. doi: 10.1159/000492023. Epub 2018 Nov 26. No abstract available.

PMID:
30476920
4.

HAX-1 overexpression in multiple myeloma is associated with poor survival.

Feng X, Kwiecinska A, Rossmann E, Bottai M, Ishikawa T, Patarroyo M, Österborg A, Porwit A, Zheng C, Fadeel B.

Br J Haematol. 2019 Apr;185(1):179-183. doi: 10.1111/bjh.15430. Epub 2018 Jun 19. No abstract available.

PMID:
29923187
5.

Proteomic Profiling of Diffuse Large B-Cell Lymphomas.

Kwiecińska A, Porwit A, Souchelnytskyi N, Kaufeldt A, Larsson C, Bajalica-Lagercrantz S, Souchelnytskyi S.

Pathobiology. 2018;85(4):211-219. doi: 10.1159/000486285. Epub 2018 Apr 4.

PMID:
29617697
6.

The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.

Jonsdottir G, Lund SH, Björkholm M, Turesson I, Hultcrantz M, Porwit A, Jethava YS, Landgren O, Kristinsson SY.

Blood Adv. 2017 Nov 22;1(25):2392-2398. doi: 10.1182/bloodadvances.2017007930. eCollection 2017 Nov 28.

7.

Ten-color 15-antibody flow cytometry panel for immunophenotyping of lymphocyte population.

Rajab A, Axler O, Leung J, Wozniak M, Porwit A.

Int J Lab Hematol. 2017 May;39 Suppl 1:76-85. doi: 10.1111/ijlh.12678.

PMID:
28447425
8.

Visualization of Cell Composition and Maturation in the Bone Marrow Using 10-Color Flow Cytometry and Radar Plots.

Jafari K, Tierens A, Rajab A, Musani R, Schuh A, Porwit A.

Cytometry B Clin Cytom. 2018 Mar;94(2):219-229. doi: 10.1002/cyto.b.21519. Epub 2017 Mar 17.

9.

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, Orfao A, Moshaver B, Brodersen LE, Loken MR, Wells DA, Subirá D, Cullen M, Te Marvelde JG, van der Velden VH, Preijers FW, Chu SC, Feuillard J, Guérin E, Psarra K, Porwit A, Saft L, Ireland R, Milne T, Béné MC, Witte BI, Della Porta MG, Kern W, van de Loosdrecht AA; IMDSFlow Working Group.

Haematologica. 2017 Feb;102(2):308-319. doi: 10.3324/haematol.2016.147835. Epub 2016 Oct 6.

10.

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Högfeldt T, Jaing C, Loughlin KM, Thissen J, Gardner S, Bahnassy AA, Gharizadeh B, Lundahl J, Österborg A, Porwit A, Zekri AN, Khaled HM, Mellstedt H, Moshfegh A.

Oncol Lett. 2016 Oct;12(4):2782-2788. Epub 2016 Aug 16.

11.

Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn Group.

Busque L, Porwit A, Day R, Olney HJ, Leber B, Éthier V, Sirhan S, Foltz L, Prchal J, Kamel-Reid S, Karsan A, Gupta V.

Am J Clin Pathol. 2016 Oct;146(4):408-22. doi: 10.1093/ajcp/aqw131. Review.

PMID:
27686169
12.
13.

Characteristics of Lymphoproliferative Disorders with More Than One Aberrant Cell Population as Detected by 10-Color Flow Cytometry.

Mahdi T, Rajab A, Padmore R, Porwit A.

Cytometry B Clin Cytom. 2018 Mar;94(2):230-238. doi: 10.1002/cyto.b.21402. Epub 2016 Aug 18.

14.
15.

Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.

Lacombe F, Bernal E, Bloxham D, Couzens S, Porta MG, Johansson U, Kern W, Macey M, Matthes T, Morilla R, Paiva A, Palacio C, Preijers F, Ratei R, Siitonen S, Allou K, Porwit A, Béné MC.

Leukemia. 2016 Aug;30(8):1769-72. doi: 10.1038/leu.2016.44. Epub 2016 Feb 29. No abstract available.

PMID:
26922887
16.

Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.

Jonsdottir G, Lund SH, Björkholm M, Turesson I, Wahlin A, Mailankody S, Blimark C, Hultcrantz M, Porwit A, Landgren O, Kristinsson SY.

Haematologica. 2016 Apr;101(4):e145-8. doi: 10.3324/haematol.2015.134049. Epub 2015 Dec 17. No abstract available.

17.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy.

Deotare U, Yee KW, Le LW, Porwit A, Tierens A, Musani R, Barth D, Torlakovic E, Schimmer A, Schuh AC, Seftel M, Minden MD, Gupta V, Hyjek E.

Am J Hematol. 2016 Mar;91(3):283-6. doi: 10.1002/ajh.24258. Epub 2016 Jan 11.

18.

Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.

Sirhan S, Busque L, Foltz L, Grewal K, Hamm C, Laferriere N, Laneuville P, Leber B, Liew E, Olney HJ, Prchal J, Porwit A, Gupta V.

Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):715-27. doi: 10.1016/j.clml.2015.07.650. Epub 2015 Aug 7.

PMID:
26433906
19.

Acute leukemias of ambiguous origin.

Porwit A, Béné MC.

Am J Clin Pathol. 2015 Sep;144(3):361-76. doi: 10.1309/AJCPSTU55DRQEGTE. Review.

PMID:
26276768
20.

Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

Porwit A.

Curr Hematol Malig Rep. 2015 Sep;10(3):309-17. doi: 10.1007/s11899-015-0272-3. Review.

PMID:
26122389
21.

ICSH guidelines for the standardization of bone marrow immunohistochemistry.

Torlakovic EE, Brynes RK, Hyjek E, Lee SH, Kreipe H, Kremer M, McKenna R, Sadahira Y, Tzankov A, Reis M, Porwit A; International Council for Standardization in Haematology.

Int J Lab Hematol. 2015 Aug;37(4):431-49. doi: 10.1111/ijlh.12365. Epub 2015 May 15.

PMID:
25977137
23.

Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.

Rajab A, Porwit A.

Cytometry B Clin Cytom. 2015 Jul-Aug;88(4):253-60. doi: 10.1002/cyto.b.21233. Epub 2015 Apr 30.

24.

Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.

Ranta S, Nilsson F, Harila-Saari A, Saft L, Tani E, Söderhäll S, Porwit A, Hultdin M, Noren-Nyström U, Heyman M.

Pediatr Blood Cancer. 2015 Jun;62(6):951-6. doi: 10.1002/pbc.25363. Epub 2014 Dec 24.

PMID:
25545289
25.

Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.

Derolf AR, Laane E, Björklund E, Saft L, Björkholm M, Porwit A.

Scand J Immunol. 2014 Dec;80(6):424-31. doi: 10.1111/sji.12223.

26.

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.

Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.

Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.

PMID:
25171702
27.

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, Della Porta MG, Ireland R, Johansson U, Matarraz S, Ogata K, Orfao A, Preijers F, Psarra K, Subirá D, Valent P, van der Velden VH, Wells D, Westers TM, Kern W, Béné MC.

Leukemia. 2014 Sep;28(9):1793-8. doi: 10.1038/leu.2014.191. Epub 2014 Jun 12.

PMID:
24919805
28.

Amplification of 2p as a genomic marker for transformation in lymphoma.

Kwiecinska A, Ichimura K, Berglund M, Dinets A, Sulaiman L, Collins VP, Larsson C, Porwit A, Lagercrantz SB.

Genes Chromosomes Cancer. 2014 Sep;53(9):750-68. doi: 10.1002/gcc.22184. Epub 2014 May 15.

29.

Relapse of acute myeloid leukemia manifested by cholecystitis: A case report and review of the literature.

Azin A, Racz JM, Carolina Jimenez M, Sunil S, Porwit A, Jackson T, Okrainec A, Quereshy F.

Int J Surg Case Rep. 2014;5(6):302-5. doi: 10.1016/j.ijscr.2014.02.003. Epub 2014 Mar 19.

30.

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q).

Saft L, Karimi M, Ghaderi M, Matolcsy A, Mufti GJ, Kulasekararaj A, Göhring G, Giagounidis A, Selleslag D, Muus P, Sanz G, Mittelman M, Bowen D, Porwit A, Fu T, Backstrom J, Fenaux P, MacBeth KJ, Hellström-Lindberg E.

Haematologica. 2014 Jun;99(6):1041-9. doi: 10.3324/haematol.2013.098103. Epub 2014 Mar 28.

31.

Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse.

Zhang X, Zhang Q, Dahlström J, Tran AN, Yang B, Gu Z, Ghaderi M, Porwit A, Jia J, Derolf A, Xu D, Björkholm M.

Leukemia. 2014 Aug;28(8):1751-4. doi: 10.1038/leu.2014.113. Epub 2014 Mar 21. No abstract available.

PMID:
24651096
32.

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Tobiasson M, Dybedahl I, Holm MS, Karimi M, Brandefors L, Garelius H, Grövdal M, Högh-Dufva I, Grønbæk K, Jansson M, Marcher C, Nilsson L, Kittang AO, Porwit A, Saft L, Möllgård L, Hellström-Lindberg E.

Blood Cancer J. 2014 Mar 7;4:e189. doi: 10.1038/bcj.2014.8.

33.

The role of diagnostic tissue in research.

Cheung CC, Torlakovic EE, Porwit A.

Pathobiology. 2014;81(5-6):298-303. doi: 10.1159/000362648. Epub 2015 Mar 16. Review.

34.

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part III - analytical issues.

Tanqri S, Vall H, Kaplan D, Hoffman B, Purvis N, Porwit A, Hunsberger B, Shankey TV; ICSH/ICCS Working Group.

Cytometry B Clin Cytom. 2013 Sep-Oct;84(5):291-308. doi: 10.1002/cyto.b.21106. Review.

35.

Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.

Högfeldt T, Johnsson P, Grandér D, Bahnassy AA, Porwit A, Eid S, Österborg A, Zekri AR, Lundahl J, Khaled MH, Mellstedt H, Moshfegh A.

Leuk Lymphoma. 2014 May;55(5):1158-65. doi: 10.3109/10428194.2013.824077. Epub 2013 Aug 31.

PMID:
23841503
36.

Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1.

Björkholm M, Sjöberg J, Nygell UA, Porwit A, Björck E.

Blood. 2013 Jun 6;121(23):4807. doi: 10.1182/blood-2013-02-469031. No abstract available.

PMID:
23744493
37.
38.

Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes.

Saft L, Björklund E, Berg E, Hellström-Lindberg E, Porwit A.

Leuk Res. 2013 Mar;37(3):266-73. doi: 10.1016/j.leukres.2012.10.010. Epub 2012 Nov 13.

PMID:
23153526
39.

Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures.

Högfeldt T, Bahnassy AA, Kwiecinska A, Osterborg A, Tamm KP, Porwit A, Zekri AR, Lundahl J, Khaled HM, Mellstedt H, Moshfegh A.

Leuk Lymphoma. 2013 May;54(5):996-1003. doi: 10.3109/10428194.2012.738365. Epub 2012 Nov 8.

PMID:
23046110
40.

Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression.

Sylvan SE, Rossmann E, Mozaffari F, Porwit A, Norin S, Karlsson C, Hansson L, Lundin J, Österborg A.

Br J Haematol. 2012 Dec;159(5):608-12. doi: 10.1111/bjh.12077. Epub 2012 Oct 9. No abstract available.

PMID:
23043283
41.

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

Daneshmanesh AH, Porwit A, Hojjat-Farsangi M, Jeddi-Tehrani M, Tamm KP, Grandér D, Lehmann S, Norin S, Shokri F, Rabbani H, Mellstedt H, Österborg A.

Leuk Lymphoma. 2013 Apr;54(4):843-50. doi: 10.3109/10428194.2012.731599. Epub 2012 Oct 9.

PMID:
22988987
42.

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.

van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M, Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Nikolova V, Ogata K, Oelschlaegel U, Orfao A, Ossenkoppele GJ, Porwit A, Platzbecker U, Preijers F, Psarra K, Richards SJ, Subirá D, Seymour JF, Tindell V, Vallespi T, Valent P, van der Velden VH, Wells DA, de Witte TM, Zettl F, Béné MC, Westers TM.

Leuk Lymphoma. 2013 Mar;54(3):472-5. doi: 10.3109/10428194.2012.718341. Epub 2012 Sep 14. Review.

PMID:
22916713
43.

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells.

Buentke E, Nordström A, Lin H, Björklund AC, Laane E, Harada M, Lu L, Tegnebratt T, Stone-Elander S, Heyman M, Söderhäll S, Porwit A, Ostenson CG, Shoshan M, Tamm KP, Grandér D.

Blood Cancer J. 2011 Jul;1(7):e31. doi: 10.1038/bcj.2011.27. Epub 2011 Jul 29.

44.

T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosis.

Darlington P, Haugom-Olsen H, von Sivers K, Wahlström J, Runold M, Svjatoha V, Porwit A, Eklund A, Grunewald J.

J Intern Med. 2012 Nov;272(5):465-71. doi: 10.1111/j.1365-2796.2012.02543.x. Epub 2012 May 12.

45.

Acute leukemias of ambiguous lineage.

Béné MC, Porwit A.

Semin Diagn Pathol. 2012 Feb;29(1):12-8. Review.

PMID:
22372202
46.

Bone marrow disorders: recent advances, Part II. Introduction.

Torlakovic EE, Porwit A, Butany J.

Semin Diagn Pathol. 2012 Feb;29(1):1. No abstract available.

PMID:
22372200
47.

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.

Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H, Czader M, Freeman S, Vyas P, Porwit A, Saft L, Westers TM, Alhan C, Cali C, van de Loosdrecht AA, Ogata K.

Haematologica. 2012 Aug;97(8):1209-17. doi: 10.3324/haematol.2011.048421. Epub 2012 Feb 7.

48.

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.

Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K, Richards SJ, Subirá D, Tindell V, Vallespi T, Valent P, van der Velden VH, de Witte TM, Wells DA, Zettl F, Béné MC, van de Loosdrecht AA.

Leukemia. 2012 Jul;26(7):1730-41. doi: 10.1038/leu.2012.30. Epub 2012 Feb 6.

PMID:
22307178
49.
50.

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis.

Buhr T, Hebeda K, Kaloutsi V, Porwit A, Van der Walt J, Kreipe H.

Haematologica. 2012 Mar;97(3):360-5. doi: 10.3324/haematol.2011.047811. Epub 2011 Nov 4.

Supplemental Content

Loading ...
Support Center